Related Experiment Video
Updated: May 12, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
Rajesh K Kharbanda1,2,3, James Kennedy2, Zahra Jamal4
1Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Insights
Routine use of cerebral embolic protection (CEP) devices during transcatheter aortic-valve implantation (TAVI) did not reduce stroke incidence. This randomized trial found no significant difference in stroke rates between TAVI with CEP and TAVI alone.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Transcatheter aortic-valve implantation (TAVI) is linked to procedure-related strokes.
- Cerebral embolic protection (CEP) devices are designed to mitigate this risk by reducing cerebral embolization.
Purpose of the Study:
- To evaluate the efficacy of routine cerebral embolic protection (CEP) devices in reducing stroke incidence following transcatheter aortic-valve implantation (TAVI).
Main Methods:
- A randomized, controlled trial involving 7635 participants undergoing TAVI across 33 UK centers.
- Participants were assigned to TAVI with a CEP device or TAVI without a CEP device (control).
- The primary outcome was stroke occurring within 72 hours post-TAVI or before hospital discharge.
Main Results:
- The incidence of the primary outcome (stroke within 72 hours) was 2.1% in the CEP group and 2.2% in the control group (P=0.94).
- Disabling stroke rates were 1.2% with CEP versus 1.4% in the control group.
- Overall rates of death and access-site complications were similar between the groups.
Conclusions:
- Routine use of cerebral embolic protection (CEP) devices does not significantly decrease the incidence of stroke within 72 hours after transcatheter aortic-valve implantation (TAVI).
- Further research may be needed to identify specific patient subgroups who might benefit from CEP during TAVI.
Background:
Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence the incidence of stroke.
Methods:
We conducted a randomized, controlled trial across 33 centers in the United Kingdom. We randomly assigned 7635 participants with aortic stenosis in a 1:1 ratio to undergo TAVI with a CEP device (CEP group) or TAVI without a CEP device (control group). The primary outcome was stroke within 72 hours after TAVI or before discharge from the hospital (if discharge occurred sooner).
Results:
A total of 3815 participants were assigned to the CEP group and 3820 to the control group. A primary-outcome event occurred in 81 of 3795 participants (2.1%) in the CEP group and in 82 of 3799 participants (2.2%) in the control group (difference, -0.02 percentage points; 95% confidence interval, -0.68 to 0.63; P = 0.94). Disabling stroke occurred in 47 participants (1.2%) in the CEP group and in 53 (1.4%) in the control group. Death occurred in 29 participants (0.8%) in the CEP group and in 26 (0.7%) in the control group. Overall access-site complications appeared to be similar in the two groups (8.1% in the CEP group and 7.7% in the control group). A total of 24 serious adverse events occurred in 22 of 3798 participants (0.6%) in the CEP group, and 13 serious adverse events occurred in 13 of 3803 participants (0.3%) in the control group.
Conclusions:
Among participants undergoing TAVI, routine use of CEP did not decrease the incidence of stroke within 72 hours. (Funded by the British Heart Foundation and Boston Scientific; BHF PROTECT-TAVI ISRCTN Registry number, ISRCTN16665769.).
More Related Videos
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Transient Ischemic Attack l: Introduction